Alykhan Shamji
10Patents
2h-index
25Co-inventors
50Inventor score
Filing activity: Sep 26, 2013 → Mar 27, 2023
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US10265321B2 | Uses of salt-inducible kinase (SIK) inhibitors | Human Necessities | 10 | Active |
| US10954242B2 | Bicyclic urea kinase inhibitors and uses thereof | Human Necessities | 7 | Active |
| US11725011B2 | Bicyclic urea kinase inhibitors and uses thereof | Human Necessities | 2 | Active |
| US9120810B2 | Compounds and methods for the treatment of isocitrate dehydrogenase related diseases | Chemistry; Metallurgy | 1 | Active |
| US11241435B2 | Uses of salt-inducible kinase (SIK) inhibitors for treating osteoporosis | Human Necessities | 1 | Active |
| US11285144B2 | Use of CDK8 inhibitors to treat diseases of inflammation and autoimmunity | Emerging Cross-Sectional Technologies | 1 | Active |
| US12398145B2 | Bicyclic urea kinase inhibitors and uses thereof | Chemistry; Metallurgy | 0 | Active |
| US11382908B2 | Compositions and methods for treating inflammatory bowel disease | Human Necessities | 0 | Active |
| US9944633B2 | Compounds and methods for the treatment of isocitrate dehydrogenase related diseases | Chemistry; Metallurgy | 0 | Active |
| US12121521B2 | Uses of salt-inducible kinase (SIK) inhibitors for treating osteoporosis | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.